Cardiovascular Journal of Africa: Vol 31 No 2 (March/April 2020)

37 / 68

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 2, March/April 2020 AFRICA 89
10. Hsueh WA, Lyon CJ, Quinones MJ. Insulin resistance and the endothe-
lium. Am J Med 2004; 117: 109–117.
11. Robak J and Gryglewski RJ. Bioactivity of flavonoids. Pol J Pharmacol
1996; 48: 555–564.
12. Koeppen BH, Roux DG. Aspalathin: a novel C-glycosylflavonoid from
Aspalathus linearis. Tetrahedron Lett 1965; 39: 3497–3503.
13. Rabe C, Steenkamp JA, Joubert E, Burger JFW, Ferreira D. Phenolic
metabolites from rooibos tea (Aspalathus linearis). Phytochemistry 1994;
35: 1559–1565.
14. Shimamura N, Miyase T, Umehara K, Warashina T, Fujii S.
Phytoestrogens from Aspalathus linearis. Biol Pharm Bull 2006; 29(6):
1271–1274.
15. Krafzyk N, Heinrich T, Porzel A, Glomb MA. Oxidation of the dihy-
drochalcone aspalathin to dimerization. J Agric Food Chem 2009; 57:
6838–6843.
16. McKay DL, Blumberg JB. A review of the bioactivity of South African
herbal teas: Rooibos (Aspalathus linearis) and Honeybush (Cyclopia
intermedia). Phytother Res 2007; 21: 1–16.
17. Marnewick JL, Rautenbach F, Venter I, Neethling H, Blackhurst DM,
Wolmarans P, Macharia M. Effects of rooibos (Aspalathus linearis ) on
oxidative stress and biochemical parameters in adults at risk for cardio-
vascular disease. J Ethnopharmacol 2011; 133: 46–52.
18. Dludla PV, Muller CJ, Louw J, Joubert E, Salie R, Opoku AR, Johnson
R. The cardioprotective effect of an aqueous extract of fermented
rooibos (Aspalathus linearis) on cultured cardiomyocytes derived from
diabetic rats. Phytomedicine 2014; 21: 595–601.
19. Pantsi WG, Marnewick JL, Esterhuyse AJ, Rautenbach F, van Rooyen
J. Rooibos (Aspalathus linearis) offers cardiac protection against ischae-
mia/reperfusion in the isolated perfused rat heart. Phytomedicine 2011;
18: 1220–1228.
20. Marnewick JL, Joubert E, Swart P, van der Westhuizen F, Gelderblom
WC. Modulation of hepatic drug metabolizing enzymes and oxidative
status by rooibos (Aspalathus linearis) and honeybush (Cyclopia interme-
dia), green and black (Camellia sinensis) teas in rats. J Agric Food Chem
2003; 51(27): 8113–8119.
21. Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP,
Poeggeler B, Hardeland R. Melatonin: Nature’s most versatile biological
signal? FEBS J 2006; 273: 2813–2838.
22. Hardeland R, Pandi-Perumal SR, Cardinali DP. Melatonin. Int J
Biochem Cell Biol 2006; 38: 313–316.
23. Rodella LF, Favero G, Rossini C, Foglio E, Reiter RJ, Rezzani R.
Endothelin-1 as a potential marker of melatonin’s therapeutic effects
in smoking-induced vasculopathy. Life Sci 2010; 87(17–18): 558–564.
24. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiol-
ogy of melatonin. Sleep Med Rev 2005; 9: 11–24.
25. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS,
Slominski AT. Melatonin membrane receptors in peripheral tissues:
Distribution and functions. Mol Cell Endocrinol 2012; 351(2): 152–166.
26. Lochner A, Genade S, Davids A, Ytrehus K, Moolman JA. Short- and
long-term effects of melatonin on myocardial post-ischemic recovery. J
Pineal Res 2006; 40: 56–63.
27. Nduhirabandi F, du Toit EF, Blackhurst D, Marais D, Lochner A.
Chronic melatonin consumption prevents obesity-related metabolic
abnormalities and protects the heart against myocardial ischaemia and
reperfusion injury in a prediabetic model of diet-induced obesity. J
Pineal Res 2011; 50: 171–182.
28. Favero G, Rodella LF, Reiter RJ, Rezzani R. Melatonin and its athero-
protective effects: A review. Mol Cell Endocrinol 2014; 382: 926–937.
29. Seabra MV, Bignotto M, Pinto LR, Tufik S. Randomized, double-blind
clinical trial, controlled with placebo, of the toxicology of chronic mela-
tonin treatment. J Pineal Res 2000; 29: 193–200.
30. Marnewick JL, Joubert E, Swart P, van der Westhuizen F, Gelderblom
WC. Modulation of hepatic drug metabolizing enzymes and oxidative
status by rooibos (Aspalathus linearis) and honeybush (Cyclopia interme-
dia), green and black (Camellia sinensis) teas in rats. J Agric Food Chem
2003; 51(27): 8113–8119.
31. Arthur H, Joubert E, de Beer D, Malherbe CJ, Witthuhn RC.
Phenylethanoid glycosides as major antioxidants in Lippia multiflora
herbal infusion and their stability during steam pasteurisation of plant
material. Food Chem 2011; 127: 581–588.
32. Joubert E, Beelders T, de Beer D, Malherbe CJ, de Villiers AJ, Sigge
GO. Variation in phenolic content and antioxidant activity of fermented
herbal tea infusions: role of production season and quality grade. J
Agric Food Chem 2012; 60: 9171–9179.
33. Ajuwon OR, Katengua-Thamahane E, van Rooyen J, Oguntibeju
OO, Marnewick JL. Protective effects of rooibos (Aspalathus linearis)
and/or red palm oil (Elaeis guineensis) supplementation on tert -butyl
hydroperoxide-induced oxidative hepatotoxicity in Wistar rats. Evid
Based Complement Alternat Med 2013; 2013 : 984273.
34. Ellerby LM, Bredesen DE. Measurement of cellular oxidation, reac-
tive oxygen species, and antioxidant enzymes during apoptosis. Meth
Enzymol 2000; 322: 413–421.
35. Jentzsch AM, Bachman H, Furst P, Biesalski HK. Improved analysis
of malondialdehyde in human body fluids. Free Radic Biol Med 1996;
20: 251–256.
36. Strijdom, H, Muller, C, Lochner, A. Direct intracellular nitric oxide
detection in isolated adult cardiomyocytes: flow cytometric analysis
using the fluorescent probe, diaminofluorescein. J Mol Cell Cardiol
2004; 37 (4): 897–902.
37. Strijdom H, Jacobs S, Hattingh S, Page C, Lochner A. Nitric oxide
production is higher in rat cardiac microvessel endothelial cells than
ventricular cardiomyocytes in baseline and hypoxic conditions: a
comparative study. FASEB J 2006; 20:14–316.
38. Wilkins RC, Kutzner BC, Truong M, Sanches-Dardon J, McLean JRN.
Analysis of radiation induced apoptosis in human lymphocytes: Flow
cytometry using annexin V and propidium iodide versus neutral comet
assay. Cytometry 2002; 48: 14–19.
39. Perry DC, Dávila-García MI, Stockmeier CA, Kellar KJ. Increased
nicotinic receptors in brains from smokers: membrane binding and auto-
radiography studies. J Pharmacol Exp Therapeut 1999; 289: 1545–1552.
40. Benowitz NL. Nicotine addiction. N Engl J Med 2010; 362(24):
2295–2303.
41. Gumustekin K, Taysi S, Alp HH, Aktas O, Oztasan N, Akcay F, et al .
Vitamin E and Hippophea rhamnoides L. extract reduce nicotine-induced
oxidative stress in rat heart. Cell Biochem Funct 2010; 28: 329–333.
42. Neogy S, Das S, Mahanapatra SK, Mandal N, Roy S. Amelioratory
effect of Andrographis paniculata Nees on liver, kidney, heart, lung
and spleen during nicotine induced oxidative stress. Environ Toxicol
Pharmacol 2008; 25: 321–328.
43. Chakkarwar VA. Fenofibrate attenuates nicotine-induced vascular
endothelial dysfunction in the rat. Vasc Pharmacol 2011; 55: 163–168.
44. Tao H, Rui C, Zheng J, Tang J, Wu L, Shi A, et al. Angiotensin
II-mediated vascular changes in aged offspring rats exposed to perinatal
nicotine. Peptides 2013; 44: 111–119.
45. Şener G, Şehirli AӦ, Ipci Y, Cetinel S, Cikler E, Gedik N, Alican I.
Taurine treatment protects against chronic nicotine-induced oxidative
changes. Fund Clin Pharmacol 2005; 19: 155–164.
46. Hong IS, Lee HY, Kim HP. Anti-oxidative effects of rooibos tea
(Aspalathus linearis) on immobilization-induced oxidative stress in rat
brain. PLoS One 2014; 9(1): e87061.